Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

117
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
117
Cancer Survival Analysis01:21

Cancer Survival Analysis

319
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
319
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

75
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
75
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

157
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
157
Actuarial Approach01:20

Actuarial Approach

53
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
53
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

84
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
84

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anchor-based disentanglement framework for incremental multi-view clustering.

Neural networks : the official journal of the International Neural Network Society·2026
Same author

Reference Material Choice Affects LC-MS/MS Infliximab Quantitation.

The journal of applied laboratory medicine·2026
Same author

Corrigendum to "Kobuvirus VP3 protein restricts the IFN-β-triggered signaling pathway by inhibiting STAT2-IRF9 and STAT2-STAT2 complex formation" [Virology 507 (2017) 161-169].

Virology·2026
Same author

A rapid phage-free platform for antigen-specific VNAR screening with BATCH system.

Protein science : a publication of the Protein Society·2026
Same author

Freeze-thaw aging and microbial colonization converts microplastics into nitrogen cycling hotspots.

Journal of hazardous materials·2026
Same author

Observation on the clinical effects of four kinds of root canal filling materials in the treatment of chronic periapical periodontitis.

American journal of translational research·2026

Related Experiment Video

Updated: May 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

201

Survival differences in malignant meningiomas: a latent class analysis using SEER data.

Bo Zhong1,2, Yan Zhang3

  • 1The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, People's Republic of China.

Discover Oncology
|February 27, 2025
PubMed
Summary

Sociodemographic factors significantly impact malignant meningioma survival. Latent class analysis identified four distinct survival groups, revealing key characteristics of patients with the longest survival times.

Keywords:
Latent class analysesMalignantMeningiomasSEERSurvival

More Related Videos

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

5.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Related Experiment Videos

Last Updated: May 25, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

201
On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis
06:48

On-Site Sampling and Extraction of Brain Tumors for Metabolomics and Lipidomics Analysis

Published on: May 31, 2020

5.8K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

Area of Science:

  • Neuro-oncology
  • Epidemiology
  • Biostatistics

Background:

  • Malignant meningioma (MM) survival varies significantly based on demographic factors.
  • Latent class analysis (LCA) is effective for identifying patient subgroups in heterogeneous populations.
  • Understanding sociodemographic heterogeneity is crucial for MM patient stratification.

Purpose of the Study:

  • To analyze sociodemographic heterogeneity in malignant meningioma (MM) patients.
  • To identify distinct patient subgroups based on survival patterns.
  • To explore correlations between sociodemographic characteristics and MM survival.

Main Methods:

  • Utilized data from 1,562 adult MM patients from the Surveillance, Epidemiology, and End Result database.
  • Employed Latent Class Analysis (LCA) to identify survival patterns.
  • Applied Bayesian network analysis to explore sociodemographic correlations within identified groups.

Main Results:

  • A 4-class latent class model provided the best fit, identifying four survival groups: highest, intermediate-high, low-to-moderate, and lowest.
  • Patients with the longest survival (93.59 months) were characterized by specific age, sex, race, ethnicity, marital status, income, and residential density.
  • Bayesian networks confirmed associations between sociodemographic factors and MM survival across different latent classes.

Conclusions:

  • Distinct differences in clinical and sociodemographic characteristics exist between MM survival groups.
  • Identifying "people-oriented" subgroup characteristics can enhance MM diagnosis and treatment strategies.
  • This study provides a foundation for personalized approaches in malignant meningioma care.